Literature DB >> 33706737

Experiences of persons in COVID-19 institutional quarantine in Uganda: a qualitative study.

Rawlance Ndejjo1, Gloria Naggayi2, Ronald Tibiita3, Richard Mugahi4, Simon P S Kibira5.   

Abstract

BACKGROUND: Quarantine has been adopted as a key public health measure to support the control of the Coronavirus disease (COVID-19) pandemic in many countries Uganda adopted institutional quarantine for individuals suspected of exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be placed in institutions like hotels and/or hostels of institutions for at least 14 days. This study explored experiences of individuals who underwent institutional quarantine in Uganda to inform measures to increase its effectiveness and reduce its associated negative impact.
METHODS: We conducted a qualitative description study using in-depth interviews with 20 purposively selected individuals who had spent time in institutional quarantine facilities. These were mainly phone-based interviews that were audio recorded and transcribed verbatim. Electronic data coding was conducted using Atlas.ti 7 software. Thematic content analysis was used to synthesize the findings with similar codes grouped to form sub-themes and ultimately study themes. The findings are presented thematically with typical participant quotes.
RESULTS: Study participants spent between 14 to 25 days in institutional quarantine. Four themes emerged describing the experiences of study participants during institutional quarantine, which determined whether participants' experiences were positive or negative. These themes were: quarantine environment including facility related factors and compliance with COVID-19 measures; quarantine management factors of entity paying the costs, communication and days spent in quarantine; individual factors comprising attitude towards quarantine, fears during and post-quarantine and coping mechanisms; and linkage to other services such as health care and post-quarantine follow-up.
CONCLUSION: The planning, management and implementation of the quarantine process is a key determinant of the experiences of individuals who undergo the measure. To improve the experience of quarantined individuals and reduce its associated negative impact, the pre-quarantine process should be managed to comply with standards, quarantined persons should be provided as much information as possible, their quarantine duration should kept short and costs of the process ought to be minimised. Furthermore, quarantine facilities should be assessed for suitability and monitored to comply with guidelines while avenues for access to healthcare for the quarantined need to be arranged and any potential stigma associated with quarantine thoroughly addressed.

Entities:  

Keywords:  COVID-19; Challenges; Coping; Experiences; Institutional; Quarantine; SARS-CoV-2

Mesh:

Year:  2021        PMID: 33706737      PMCID: PMC7947936          DOI: 10.1186/s12889-021-10519-z

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  17 in total

1.  The origin of quarantine.

Authors:  Paul S Sehdev
Journal:  Clin Infect Dis       Date:  2002-11-01       Impact factor: 9.079

2.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Authors:  Allison Tong; Peter Sainsbury; Jonathan Craig
Journal:  Int J Qual Health Care       Date:  2007-09-14       Impact factor: 2.038

3.  Psychological and behavioural reactions to the bombings in London on 7 July 2005: cross sectional survey of a representative sample of Londoners.

Authors:  G James Rubin; Chris R Brewin; Neil Greenberg; John Simpson; Simon Wessely
Journal:  BMJ       Date:  2005-08-26

4.  Simulating the effect of quarantine on the spread of the 1918-19 flu in central Canada.

Authors:  Lisa Sattenspiel; D Ann Herring
Journal:  Bull Math Biol       Date:  2003-01       Impact factor: 1.758

5.  Mental health status of people isolated due to Middle East Respiratory Syndrome.

Authors:  Hyunsuk Jeong; Hyeon Woo Yim; Yeong-Jun Song; Moran Ki; Jung-Ah Min; Juhee Cho; Jeong-Ho Chae
Journal:  Epidemiol Health       Date:  2016-11-05

6.  The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemic in the final phase of the current outbreak in China.

Authors:  Biao Tang; Fan Xia; Sanyi Tang; Nicola Luigi Bragazzi; Qian Li; Xiaodan Sun; Juhua Liang; Yanni Xiao; Jianhong Wu
Journal:  Int J Infect Dis       Date:  2020-06-04       Impact factor: 3.623

7.  Quarantine during COVID-19 outbreak: Changes in diet and physical activity increase the risk of cardiovascular disease.

Authors:  Anna V Mattioli; Susanna Sciomer; Camilla Cocchi; Silvia Maffei; Sabina Gallina
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-05-30       Impact factor: 4.222

8.  Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.

Authors:  Barbara Nussbaumer-Streit; Verena Mayr; Andreea Iulia Dobrescu; Andrea Chapman; Emma Persad; Irma Klerings; Gernot Wagner; Uwe Siebert; Claudia Christof; Casey Zachariah; Gerald Gartlehner
Journal:  Cochrane Database Syst Rev       Date:  2020-04-08

9.  The concept of quarantine in history: from plague to SARS.

Authors:  Gian Franco Gensini; Magdi H Yacoub; Andrea A Conti
Journal:  J Infect       Date:  2004-11       Impact factor: 6.072

10.  WHO Declares COVID-19 a Pandemic.

Authors:  Domenico Cucinotta; Maurizio Vanelli
Journal:  Acta Biomed       Date:  2020-03-19
View more
  2 in total

1.  Kopfkino: Phases of quarantine among asymptomatic SARS-COV-2 carriers in Germany.

Authors:  Ferdinand Uellner; Freda Röhr; Claudia Denkinger; Till Bärnighausen; Andreas Deckert; Aurelia Souares; Shannon A McMahon
Journal:  SSM Qual Res Health       Date:  2022-03-22

2.  Exploring experiences of quarantined people during the early phase of COVID-19 outbreak in Southern Nations Nationalities and Peoples' Region of Ethiopia: A qualitative study.

Authors:  Ararso Baru Olani; Nega Degefa; Zeleke Aschalew; Mekdim Kassa; Tesfaye Feleke; Girma Gura; Sarah Namee Wambete
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.